# Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction

> **NCT02779634** · PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** ubiquinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02779634
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779634, "Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02779634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*